Formamide

Formamide

SCHEMBL12498232

CCc1cccc(-c2ccc([N+](=O)[O-])cc2)c1CC.NC=O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 2/20 0.39
APP P05067 1/20 0.38
PRKCZ Q05513 1/20 0.38
HTT P42858 1/20 0.37
AR P10275 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTR7 P34969 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formamide SCHEMBL15663241 0.81 DPP4 (0.44) KMT2AADORA2AHSD17B10
Formamide SCHEMBL12498254 0.75 SMN1; SMN2 (0.45) LOXL2MEN1KMT2AMAPTAPP
SCHEMBL28789839 0.73 POLB (0.41) LOXL2CDK1CCNB1MEN1KMT2A
Formamide SCHEMBL16969080 0.73 APP (0.46) MAPTAPPGAAADORA3ADORA2A
SCHEMBL6438986 0.72 HTR7 (0.43) MEN1KMT2APOLBAPPAR
Formamide SCHEMBL19272521 0.71 TAAR1 (0.38) MEN1KMT2AMAPTCYP3A4
SCHEMBL473270 0.71 PDCD1 (0.50) KMT2A
Formamide SCHEMBL12497334 0.71 CA12 (0.40) LOXL2MEN1KMT2AAPPCYP1A2
SCHEMBL9194437 0.71 DPP4 (0.58) LOXL2MEN1KMT2APOLBMAPT
SCHEMBL5843026 0.71 POLB (0.45) LOXL2CDK1CCNB1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012119035-A1 ANTI-AMYLOID COMPOUNDS AND METHODS TREVENTIS CORPORATION (US) 2012-09-07 WO disclosed